EP2869813
Sprauta
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
25.1.2013EP published:
21.11.2018EP application number:
13701276.1
EP translation filed:
18.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
24.1.2033Expiry date:
24.1.2023
Title:
SYRINGE
Timeline
Today
25.1.2013EP application
21.11.2018EP Publication
18.2.2019Translation submitted
15.3.2019Registration published
24.1.2023Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
SIGG, JuergenAddress:
Basel, CH
Name:
ROYER, ChristopheAddress:
Basel, CH
Name:
BRYANT, Andrew MarkAddress:
Basel, CH
Name:
BUETTGEN, Heinrich MartinAddress:
Basel, CH
Name:
PICCI, MarieAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
12174860Date:
3.7.2012Country:
EP
Number:
12189649Date:
23.10.2012Country:
EP
Number:
202012011016 UDate:
16.11.2012Country:
DE
Number:
2012101677Date:
16.11.2012Country:
AU
Number:
2012101678Date:
16.11.2012Country:
AU
Number:
202012011260 UDate:
23.11.2012Country:
DE
Number:
202012011259 UDate:
23.11.2012Country:
DE
Number:
12195360Date:
3.12.2012Country:
EP
Number:
202013000688 UDate:
23.1.2013Country:
DE
Number:
2013100071Date:
23.1.2013Country:
AU
Number:
2013100070Date:
23.1.2013Country:
AU
Classification
Categories:
A61K 9/00, A61M 5/28, A61M 5/31, A61M 5/315
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 21.12.2018
Expires: 24.1.2020
Payer: Árnason Faktor
Number: 8
Paid: 31.12.2019
Expires: 24.1.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 29.12.2020
Expires: 24.1.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.12.2021
Expires: 24.1.2023
Payer: Árnason Faktor ehf.